Bronchial asthma as neurogenic paroxysmal inflammatory disease: A randomized trial with carbamazepine

Respiratory Medicine

Volumn 100, Issue 11, 2006, Pages 1988-1996

  Lomia, M ^a   Tchelidze, T ^b   Pruidze, M ^c  

^a REA Centre   (Georgia)

^b Evidence CPR   (Georgia)

^c Centre of Chinese Medicine   (Georgia)

Author keywords

Antiepileptic drugs; Asthma; Carbamazepine; Efficacy; Placebo controlled trial

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBAMAZEPINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; PLACEBO; SALBUTAMOL; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SOMNOLENCE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ANTICONVULSANTS; ASTHMA; BRONCHODILATOR AGENTS; CARBAMAZEPINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PERIPHERAL NERVES; TREATMENT OUTCOME;

EID: 33749326638     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.02.018     Document Type: Article

References (27)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention. National Institutes of Health, NHLBI/WHO workshop report, update 2004.
2. Masoli M., Fabian D., Holt S., and Beasley R. GINA Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59 5 (2004) 469-478
3. Asthma mortality: summary of a round-table discussion, New York, January 1997. Eur Respir J 13 (1999) 221-224
4. Joos G.F., De Swert K.O., Schelfhout V., and Pauwels R.A. The Role of Neural Inflammation in Asthma and Chronic Obstructive Pulmonary Disease. Ann NY Acad Sci 992 (2003) 218-230
5. Canadian asthma consensus report. CMAJ 199;161(11Suppl):S1-5.
6. Kryzhanovskii GN. Determinant structures in pathologic conditions of the nervous system. Generator mechanisms of neuropathologic syndromes. Meditsina, Moscow, 1980.
7. Hardebo J.E. A cortical excitatory wave may cause both the aura and the headache of migraine. Cephalalgia 12 2 (1992) 75-80 [review]
8. Strittmatter M., Grauer M., Isenberg E., Hamann G., Fischer C., Hoffmann K.H., et al. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache 37 4 (1997) 211-216
9. Hering R., and Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 12 2 (1992) 81-84
10. Corbo J. The role of anticonvulsants in preventive migraine therapy. Curr Pain Headache Rep 7 1 (2003) 63-66
11. Dalessio D.J. The major neuralgias, postinfection neuritis, and atypical facial pain. In: Dalessio D.J. (Ed). Wolff's headache and other head pain (1987), Oxford University Press, Oxford, New York 266-288
12. Spina E., and Perugi G. Antiepileptic drugs: indications other than epilepsy (review). Epileptic Disorders 6 2 (2004) 57-75
13. Lomia M., Pruidze M., and Chapichadze Z. Bronchial asthma as neurogenic paroxysmal disease-high effectiveness of carbamazepine in asthma monotherapy. Eur Respir J 24 suppl. 48 (2004) 221s
14. Lomia M., Chapichadze Z., Pruidze M., and Platonov P. Efficacy of monotherapy with carbamazepine and valproic acid in patients with bronchial asthma: is asthma a neurological disease?. Internet J Neurol 4 1 (2005)
15. Ivanova NA. Epilepsy in structure of concomitant diseases in children with bronchial asthma and principles of complex therapy [Russian]. In: Modern principles of treatment of children with relapsing and chronic bronchial and lungs diseases. Leningrad; 1987. p. 89-91.
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136 (1987) 225-244
17. Lomia M., Pruidze M., and Chapichadze Z. Bronchial asthma as neurogenic paroxysmal inflammatory disease-high effectiveness of antiepileptic drug oxcarbazepine in asthma monotherapy. Eur Respir J 26 suppl. 49 (2005) 466s
18. Bianchi M., Rossoni G., Maggi R., Panerai A.E., and Berti F. Effects of carbamazepine on plasma extravasation and bronchoconstriction induced by substance P, capsaicin, acetaldehyde and histamine in guinea-pig lower airways. Fundam Clin Pharmacol 12 1 (1998) 58-63
19. Lipton R.B., Goldstein J., Baggish J.S., Yataco A.R., Sorrentino J.V., and Quiring J.N. Aspirin is efficacious for the treatment of acute migraine. Headache 45 4 (2005) 283-292
20. Covar R.A., Macomber B.A., and Szefler S.J. Medications as asthma triggers. Immunol Allergy Clin North Am 25 1 (2005) 169-190
21. Snow V., Weiss K., Wall E.M., and Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 137 10 (2002) 840-849
22. Smith K.J., and Skelton H.G. Accidental success with carbamazepine for psoriatic erythroderma. N Engl J Med 335 26 (1996) 1999-2000
23. Goyal N.N., Dhurat R.S., and Jerajani H.R. Carbamazepine in Reuter's sindrome. Sex Trans Inf 76 (2000) 220
24. Raychaudhuri S.P., and Raychaudhuri S.K. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res 146 (2004) 433-437
25. Joseph T., Kurian J., Warwick D.J., and Friedmann P.S. Unilateral remission of psoriasis following traumatic nerve palsy. Br J Dermatol 152 (2005) 185-186
26. Farber E.M., Nickoloff B.J., Recht B., and Fraki J.E. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 14 (1986) 305-311
27. Schon M.P., and Boehncke W.-H. Psoriasis. N Engl J Med 352 18 (2005) 1899-1912